| Low-dose Chemotherapy Combined with an Antiangiogenic Drug Reduces Human Glioma Growth in Vivo L Bello, G Carrabba, C Giussani, V Lucini, F Cerutti, F Scaglione, ... Cancer research 61 (20), 7501-7506, 2001 | 239 | 2001 |
| The melatonin receptor in the human brain: cloning experiments and distribution studies C Mazzucchelli, M Pannacci, R Nonno, V Lucini, F Fraschini, BM Stankov Molecular brain research 39 (1-2), 117-126, 1996 | 228 | 1996 |
| Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache M Leone, V Lucini, D D'amico, F Moschiano, C Maltempo, F Fraschini, ... Cephalalgia 15 (3), 224-229, 1995 | 188 | 1995 |
| Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2 L Bello, V Lucini, G Carrabba, C Giussani, M Machluf, M Pluderi, D Nikas, ... Cancer research 61 (24), 8730-8736, 2001 | 175 | 2001 |
| Characterization and mapping of melatonin receptors in the brain of three mammalian species: rabbit, horse and sheep: A comparative in vitro binding study B Stankov, B Cozzi, V Lucini, P Fumagalli, F Scaglione, F Fraschini Neuroendocrinology 53 (3), 214-221, 1991 | 134 | 1991 |
| 2-[N-Acylamino(C1−C3)alkyl]indoles as MT1 Melatonin Receptor Partial Agonists, Antagonists, and Putative Inverse Agonists G Spadoni, C Balsamini, A Bedini, G Diamantini, B Di Giacomo, A Tontini, ... Journal of medicinal chemistry 41 (19), 3624-3634, 1998 | 128 | 1998 |
| Melatonin signal transduction and mechanism of action in the central nervous system: using the rabbit cortex as a model. B Stankov, G Biella, C Panara, V Lucini, S Capsoni, J Fauteck, B Cozzi, ... Endocrinology 130 (4), 2152-2159, 1992 | 107 | 1992 |
| N-(Substituted-anilinoethyl)amides: Design, Synthesis, and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands S Rivara, A Lodola, M Mor, A Bedini, G Spadoni, V Lucini, M Pannacci, ... Journal of medicinal chemistry 50 (26), 6618-6626, 2007 | 102 | 2007 |
| Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice L Ponzoni, M Moretti, M Sala, F Fasoli, V Mucchietto, V Lucini, ... European Neuropsychopharmacology 25 (10), 1775-1786, 2015 | 101 | 2015 |
| Autoradiographic localization of putative melatonin receptors in the brains of two Old World primates: Cercopithecus aethiops and Papio ursinus B Stankov, S Capsoni, V Lucini, J Fauteck, S Gatti, B Gridelli, G Biella, ... Neuroscience 52 (2), 459-468, 1993 | 101 | 1993 |
| Melatonin receptor ligands: Synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study M Mor, S Rivara, C Silva, F Bordi, PV Plazzi, G Spadoni, G Diamantini, ... Journal of medicinal chemistry 41 (20), 3831-3844, 1998 | 100 | 1998 |
| Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia F Scaglione, S Esposito, S Leone, V Lucini, M Pannacci, L Ma, ... European Respiratory Journal 34 (2), 394-400, 2009 | 98 | 2009 |
| Comparison of the Potency of Different Brands of Serenoa Repens Extract on 5α-Reductase Types I and II in Prostatic Co-Cultured Epithelial and Fibroblast Cells F Scaglione, V Lucini, M Pannacci, A Caronno, C Leone Pharmacology 82 (4), 270-275, 2008 | 97 | 2008 |
| Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1‐antagonists R Nonno, M Pannacci, V Lucini, D Angeloni, F Fraschini, BM Stankov British journal of pharmacology 127 (5), 1288-1294, 1999 | 97 | 1999 |
| 2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity G Spadoni, B Stankov, A Duranti, G Biella, V Lucini, A Salvatori, ... Journal of medicinal chemistry 36 (25), 4069-4074, 1993 | 92 | 1993 |
| Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study G Spadoni, C Balsamini, G Diamantini, B Di Giacomo, G Tarzia, M Mor, ... Journal of medicinal chemistry 40 (13), 1990-2002, 1997 | 91 | 1997 |
| Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache M Leone, V Lucini, D D'Amico, L Grazzi, F Moschiano, F Fraschini, ... Cephalalgia 18 (10), 664-667, 1998 | 83 | 1998 |
| Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models F Pisati, M Belicchi, F Acerbi, C Marchesi, C Giussani, M Gavina, ... Cancer Research 67 (7), 3054-3063, 2007 | 77 | 2007 |
| Suppression of malignant glioma recurrence in a newly developed animal model by endogenous inhibitors L Bello, C Giussani, G Carrabba, M Pluderi, V Lucini, M Pannacci, ... Clinical cancer research 8 (11), 3539-3548, 2002 | 77 | 2002 |
| 2-N-Acylaminoalkylindoles: Design and Quantitative Structure−Activity Relationship Studies Leading to MT2-Selective Melatonin Antagonists G Spadoni, C Balsamini, G Diamantini, A Tontini, G Tarzia, M Mor, ... Journal of medicinal chemistry 44 (18), 2900-2912, 2001 | 69 | 2001 |
